(AP) -- A pill that has long been used to treat HIV has moved one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS.
May 8, 2012
0
0
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science ...
May 2, 2012
0
0
California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.
Apr 23, 2012
0
0
One in four HIV patients was found to have been sexually abused as a child, according to a two-year Duke University study of more than 600 HIV patients. Traumatic childhood experiences were also linked to worse health outcomes ...
Mar 14, 2012
0
0
Mobile phones could play a valuable role in helping HIV patients to take their medication every day, according to a new Cochrane Systematic Review. The researchers found that patients were less likely to miss doses if they ...
Mar 13, 2012
0
0
Sexually active adults aged 45 and over are being encouraged to pay more thought to safe sex in line with recent figures showing that STIs in 50-90 year olds have doubled in the past ten years.
Feb 3, 2012
0
0
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to ...
Jan 18, 2012
0
0
An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease (GvHD) in blood cancer patients following allogeneic stem cell transplantation (ASCT), according ...
Dec 13, 2011
1
0
People with HIV have a 15 years longer life expectancy thanks to improved treatments over the past 13 years, according to a new study published in the British Medical Journal today.
Oct 12, 2011
1
0
A landmark study by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia (UBC) shows that patients in Africa receiving combination antiretroviral therapy (cART) for HIV can expect to live ...
Jul 18, 2011
2
0
